Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV000144329 | SCV002540714 | uncertain significance | Angelman syndrome | 2022-06-30 | reviewed by expert panel | curation | The c.2355T>C p.(Phe785=) variant in UBE3A (NM_130838.2) is present in gnomAD v2.1.1 at a frequency of 0.0062% in the African/African-American sub population (no criteria met). The silent p.(Phe785=) variant is not predicted to affect splicing using multiple computational tools, however this affects a highly conserved nucleotide (BP7 not met). The p.(Phe785=) variant has been observed in at least 1 unaffected mother of a patient with Angelman syndrome (PMID: 25212744) (BS2 not met). In summary, the c.2355T>C p.(Phe785=) variant in UBE3A is classified as a Variant of Uncertain Significance based on the ACMG/AMP criteria (no criteria met). |
Gene |
RCV000995272 | SCV000169716 | likely benign | not provided | 2021-05-03 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 25212744) |
Ce |
RCV000995272 | SCV001149363 | likely benign | not provided | 2019-02-01 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000144329 | SCV001603656 | likely benign | Angelman syndrome | 2023-04-10 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000144329 | SCV000188506 | uncertain significance | Angelman syndrome | 2014-02-14 | no assertion criteria provided | clinical testing | possible diagnosis of Angelman syndrome |